<DOC>
	<DOCNO>NCT02248311</DOCNO>
	<brief_summary>Current method base traditional Cardiovascular risk factor clinically useful identify Type 2 Diabetes patient risk develop acute Cardiovascular ischemic event ( ie.myocardial infarction stroke ) . In addition , Cardiovascular ischemic event Type 2 Diabetes population bad prognosis general population . In fact , sufficient experimental evidence indicate diabetes exaggerate deleterious effect ischemic event worsen outcome . A prolonged sub-clinical phase exist Cardiovascular event occur Type 2 Diabetes patient . Therefore , new strategy aim identify patient subclinical Cardiovascular Diabetes , consequently , prone develop Cardiovascular event challenge meet .</brief_summary>
	<brief_title>`` Preventing Cardiovascular Ischemic Events Arresting Their Consequences Type 2 Diabetic Population</brief_title>
	<detailed_description>Objectives 1 ) To examine whether extension degree microangiopathy independent risk factor silent myocardial brain ischemia . 2 ) To evaluate whether degree extension microangiopathy predictor CV event poor outcome . 3 ) To evaluate whether new score base extension degree microangiopathy permit u improve current method use identify patient risk CVD outcome . 4 ) To determine whether presence degree NAFLD independent Cardiovascular disease risk factor represent extra-value score base extension degree microangiopathy . Secondary objective : 1 ) To examine usefulness select serum biomarkers identify diabetic patient risk Cardiovascular disease 2 ) To evaluate whether select biomarkers related degree extension microangiopathy outcome cardiovascular event . 3 ) To good define mean microalbuminuria type 2 diabetic population ( glomerular involvement vs. index generalize endothelial dysfunction )</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Cerebrovascular Disorders</mesh_term>
	<criteria>) Age 5079 year ; b ) History type 2diabetes least one year . Diabetes define follow American Diabetic Association criterion : fast glucose level least 126 mg/dl [ 7.0 mmol/l ] two separate analysis , nonfasting glucose level least 200 mg/dl [ 11.1 mmol/l ] selfreported history physiciandiagnosed diabetes treatment diabetes ) Past medical history Cardiovascular event ; b ) Type 1 diabetes ; c ) Contraindication PETCT MRI ) Other concomitant disease associate short life expectancy</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>